Storage device for an inhaler
Latest Novartis AG Patents:
- Tricyclic AKR1C3 dependent KARS inhibitors
- Treatment of cancer using GFR alpha-4 chimeric antigen receptor
- Methods of treating HIV-HAART induced partial lipodystrophy with FGF21 protein variant FC fusion proteins
- Solid forms comprising an oxime ether compound, compositions and methods of use thereof
- Urea compounds and compositions as SMARCA2/BRM ATPase inhibitors
Description
Claims
The ornamental design for a storage device for an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D644424
Type: Grant
Filed: Sep 2, 2010
Date of Patent: Sep 6, 2011
Assignee: Novartis AG (Basel)
Inventors: Stephen Paboojian (Basel), George Perkins (Cambridge), Andrew Pidgeon (Cambridge), Lai Chiu Tang (Cambridge), Edward Vernon-Harcourt (West Sussex)
Primary Examiner: Catheri Oliver
Attorney: Design IP
Application Number: 29/369,081
Type: Grant
Filed: Sep 2, 2010
Date of Patent: Sep 6, 2011
Assignee: Novartis AG (Basel)
Inventors: Stephen Paboojian (Basel), George Perkins (Cambridge), Andrew Pidgeon (Cambridge), Lai Chiu Tang (Cambridge), Edward Vernon-Harcourt (West Sussex)
Primary Examiner: Catheri Oliver
Attorney: Design IP
Application Number: 29/369,081
Classifications
Current U.S. Class:
D3/203.1